Product
CYL-02
1 clinical trial
1 indication
Indication
Pancreatic adenocarcinomaClinical trial
Phase 2 Gene Therapy Trial of Locally Advanced Pancreatic Adenocarcinoma Using Intratumoral Injection of CYL-02 in Combination With GemcitabineStatus: Completed, Estimated PCD: 2022-06-30